Patent Yard Sign in
Expired Canadian patentCanada

Benzothiazepine derivatives

CA 1338417 C · Owner: E.R. Squibb & Sons, Inc. · Inventors: Atwal, Karnail Singh; Floyd, David Mack

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Calcium channel blocking activity is, exhibited by compounds having the formula or a pharmaceutically accpetable salt thereof wherein the stereochemistry at the chiral centers in the 2 and 3-positions of the benzothiazepine nucleus is cis, and wherein R1 is alkyl, aryl, arylalkyl, alkenyl or alkynyl;, R2 and R5 are each independently hydrogen alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, halogen or trifluoromethyl; and R3 and R4 are each independently alkyl or cycloalkyl or R3 and R4 together with the nitrogen atom to which they are attached are pyrrolidinyl, piperidinyl or morpholinyl.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted June 25, 1996. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 25, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 14, 1987
GrantedJune 25, 1996
Term endedJune 25, 2013
Patent numberCA 1338417 C
Classification (IPC)C07D281/10 +2 more

Timeline

Timeline From CIPO dates

198819911994199720002003200620092012Application filedJuly 14, 1987Patent grantedJune 25, 1996Term endedJune 25, 2013

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.